ESSA Pharma Inc. — Investor Relations & Filings
ESSA Pharma Inc. is a clinical-stage pharmaceutical company focused on the development of small molecule drugs for the treatment of prostate cancer. The company's core strategy is to develop novel therapies that target the N-terminal domain (NTD) of the androgen receptor (AR). This approach represents a distinct mechanism of action compared to existing treatments that target the ligand-binding domain of the AR. Its lead clinical candidate, EPI-7386, is an investigational oral drug designed to inhibit AR activity and is being developed for patients with castration-resistant prostate cancer (CRPC), including those whose disease has become resistant to current standard-of-care therapies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Regulatory Filings 2025 | 2025-11-17 | English | |
| Major Shareholding Notification 2025 | 2025-11-14 | English | |
| Major Shareholding Notification 2025 | 2025-11-14 | English | |
| 15-12G | 2025-10-28 | English | |
| OWNERSHIP DOCUMENT | 2025-10-15 | English | |
| OWNERSHIP DOCUMENT | 2025-10-15 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 12852931 | Regulatory Filings 2025 | 2025-11-17 | English | ||
| 12852932 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 12852935 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 12852934 | 15-12G | 2025-10-28 | English | ||
| 12852933 | OWNERSHIP DOCUMENT | 2025-10-15 | English | ||
| 12852936 | OWNERSHIP DOCUMENT | 2025-10-15 | English | ||
| 12852937 | OWNERSHIP DOCUMENT | 2025-10-15 | English | ||
| 12852938 | OWNERSHIP DOCUMENT | 2025-10-15 | English | ||
| 12852939 | OWNERSHIP DOCUMENT | 2025-10-15 | English | ||
| 12852940 | OWNERSHIP DOCUMENT | 2025-10-15 | English | ||
| 12852941 | OWNERSHIP DOCUMENT | 2025-10-15 | English | ||
| 12852942 | POS AM | 2025-10-15 | English | ||
| 12852943 | S-8 POS | 2025-10-15 | English | ||
| 12852944 | S-8 POS | 2025-10-15 | English | ||
| 12852945 | S-8 POS | 2025-10-15 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Dermapharm Holding SE
A manufacturer of patent-free branded pharmaceuticals and h…
|
DMP | DE | Manufacturing |
|
Dermata Therapeutics, Inc.
Medical dermatology company developing and commercializing …
|
DRMA | US | Manufacturing |
|
Desh Rakshak Aushdhalaya Ltd.
Manufacturer of GMP-certified Ayurvedic and herbal medicine…
|
531521 | IN | Manufacturing |
|
Design Therapeutics, Inc.
Clinical-stage biopharma developing small molecule therapie…
|
DSGN | US | Manufacturing |
|
Deutsche Biotech Innovativ AG
Develops therapeutics for serious diseases using innovative…
|
DBI | DE | Manufacturing |
|
DEVA HOLDİNG A.Ş.
Develops, produces, and markets human medicines, APIs, and …
|
DEVA | ES | Manufacturing |
|
Devonian Health Group Inc
Clinical-stage botanical pharmaceutical company focused on …
|
GSD | CA | Manufacturing |
|
Devyser Diagnostics
Develops DNA testing kits for hereditary diseases, oncology…
|
DVYSR | SE | Manufacturing |
|
DexTech Medical AB
Develops drug candidates for urological oncology, focusing …
|
DEX | SE | Manufacturing |
|
Dezhan Healthcare Company Limited
Researches and produces cardiovascular chemical drugs and o…
|
000813 | CN | Manufacturing |
ESSA Pharma Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35249/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35249 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35249 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35249 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35249}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ESSA Pharma Inc. (id: 35249)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.